Published on June 1, 2026, in the journal Development, an international research team has uncovered a fundamental molecular mechanism governing the formation of tendons and ligaments. Professor Chisa Shukunami at Hiroshima University’s Graduate School of Biomedical and Health Sciences was part of the team that identified a novel, evolutionarily conserved DNA enhancer that specifically controls the expression of Scleraxis (Scx), offering new pathways for regenerative medicine in avascular musculoskeletal tissues.
Decoding the Genetic Switches of Musculoskeletal Integration
Tendons, ligaments, and their attachment sites—known as entheses—play a critical role in musculoskeletal integration. Yet, because these structures feature poor vascularization, they exhibit a limited capacity for functional repair after injury. When injuries occur or mechanical stress builds up, patients often face pain and functional impairment, clinically categorized as enthesopathy. For years, scientists have understood that Scleraxis (Scx), a basic helix-loop-helix transcription factor, is vital for the formation and maturation of these tissues. Furthermore, Scx is reactivated in adults during tissue repair and adaptation to mechanical loading, and its loss leads to improper development of tendons, ligaments, and entheses.
To pinpoint how this critical factor is deployed during embryonic growth, the research team investigated genetic enhancers—specialized DNA sequences that act as molecular switches to control when and where specific genes are activated. Using transgenic reporter mice to visualize live tissue activity, the investigators tracked down a 5.3 kb downstream Scleraxis enhancer, designated as the dSE, which drove robust, stable, and faithful reporter activity across developing musculoskeletal structures.
Isolating the Conserved Scleraxis Enhancer
Drilling down into the dSE region, the team isolated a much smaller segment: a 343 bp conserved Scleraxis enhancer, known as the CSE. This particular sequence exhibits remarkable evolutionary persistence. According to findings published in Development, the CSE is highly conserved from lobe-finned fishes, such as coelacanths, up to tetrapods, including humans. Despite millions of years of divergent evolution, the CSE retains its ability to recapitulate Scx gene expression in developing limbs.
To test the functional relevance of this sequence in vivo, the researchers engineered mice lacking the CSE. These genetically modified subjects displayed a marked reduction in endogenous Scx gene expression during early limb development. Consequently, these mice failed to form the deltoid tuberosity (DT)—the prominent bone ridge on the humerus where the deltoid muscle attaches to support shoulder movement. Without precise activation of the CSE during a specific developmental window, normal skeletal architecture is disrupted, resulting in a proximal shift of the brachialis muscle alongside the loss of the deltoid tuberosity.
Implications for Regenerative Medicine
Interestingly, the study revealed a compensatory recovery mechanism. Despite the early suppression of Scx expression in CSE-deficient models, Scx levels gradually recovered at later developmental stages. The research team suggests this late-stage rebound is mediated by additional regulatory elements residing within the larger 5.3 kb dSE region.
As Professor Chisa Shukunami noted regarding the broader implications for human health: Since tendons, ligaments, and entheses are avascular and have limited regenerative capacity, understanding how Scx gene expression is controlled is crucial for understanding the molecular basis of tendon and ligament formation.
By mapping out genome editing-mediated deletions and identifying the specific regulatory switches that drive musculoskeletal development, this research establishes a scientific foundation for future regenerative therapies aiming to repair damaged human tendons and ligaments.
Worth a look
